Media Summary: International Webinar: Impurity Profiling of Pharmaceuticals Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. This is ... Click here to register for free and to view the entire

Pharmaceutical Volatile Impurity Identification Webinar - Detailed Analysis & Overview

International Webinar: Impurity Profiling of Pharmaceuticals Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. This is ... Click here to register for free and to view the entire Course leader talking about the EMEA Guideline on the limits of Genotoxic Presenter: Dr Christian Zeine, Global Product Manager In this video, we delve into the crucial topic of

When widely used blood pressure drugs were found to be contaminated with a carcinogenic Key Highlights: Potential sources of elemental

Photo Gallery

Pharmaceutical Volatile Impurity Identification Webinar with AstraZeneca
International Webinar: Impurity Profiling of Pharmaceuticals
Selected Case Studies and Impurity Strategies for Drug Substances by Paul Wrezel, Ph.D. (Full)
Novel MS Techniques Speed Detection of Biopharmaceutical Product and Process Impurities
Pharmaceutical Impurity Characterisation – Strategies for Success
WEBINAR: EMEA guideline on genotoxic
Impurity  Identification
Purity is a Virtue: A Practical Guide to the Reporting of Impurities
Characterisation of non-compendial reference standards for impurities
Impurity Profiling in Pharmaceuticals
Identification, Control and Qualification of Impurities
Our impact: Valsartan pharmaceutical impurities
View Detailed Profile
Pharmaceutical Volatile Impurity Identification Webinar with AstraZeneca

Pharmaceutical Volatile Impurity Identification Webinar with AstraZeneca

Hear from scientists at

International Webinar: Impurity Profiling of Pharmaceuticals

International Webinar: Impurity Profiling of Pharmaceuticals

International Webinar: Impurity Profiling of Pharmaceuticals

Selected Case Studies and Impurity Strategies for Drug Substances by Paul Wrezel, Ph.D. (Full)

Selected Case Studies and Impurity Strategies for Drug Substances by Paul Wrezel, Ph.D. (Full)

Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. This is ...

Novel MS Techniques Speed Detection of Biopharmaceutical Product and Process Impurities

Novel MS Techniques Speed Detection of Biopharmaceutical Product and Process Impurities

Click here to register for free and to view the entire

Pharmaceutical Impurity Characterisation – Strategies for Success

Pharmaceutical Impurity Characterisation – Strategies for Success

The need to

WEBINAR: EMEA guideline on genotoxic

WEBINAR: EMEA guideline on genotoxic

Course leader talking about the EMEA Guideline on the limits of Genotoxic

Impurity  Identification

Impurity Identification

Impurity Identification

Purity is a Virtue: A Practical Guide to the Reporting of Impurities

Purity is a Virtue: A Practical Guide to the Reporting of Impurities

Many

Characterisation of non-compendial reference standards for impurities

Characterisation of non-compendial reference standards for impurities

Presenter: Dr Christian Zeine, Global Product Manager

Impurity Profiling in Pharmaceuticals

Impurity Profiling in Pharmaceuticals

In this video, we delve into the crucial topic of

Identification, Control and Qualification of Impurities

Identification, Control and Qualification of Impurities

Identification

Our impact: Valsartan pharmaceutical impurities

Our impact: Valsartan pharmaceutical impurities

When widely used blood pressure drugs were found to be contaminated with a carcinogenic

“West AP Webinar: Requirements for the Latest Elemental Impurities Regulation”

“West AP Webinar: Requirements for the Latest Elemental Impurities Regulation”

Key Highlights: Potential sources of elemental